Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
KEY FEATURES CJC-1295 NO DAC + IPA lyophilised research-grade peptide 5mg/5mg per vial Independent HPLC-MS verified to 99.00% purity (CoA on public Lab Results portal) Single-batch fill, single-batch chromatogram no blending across lots Synthesised in accredited contract laboratories with full QA paper trail Crimp-sealed, tamper-evident research vial in unbranded outer packaging Dispatched from Australia on Auspost Express with insulated cold-pack option SPECIFICATIONS Product Name CJC-1295 NO DAC + IPA Category Proprietary Research Blends Grade Research grade laboratory use only Quantity 5mg/5mg per vial Form Lyophilised powder cake Purity 99.00% verified by HPLC-MS Appearance White to off-white lyophilised solid Storage 28 C lyophilised
Coverage varies by plan type
For patients comparing these medications, understanding their side effect profiles , the dosage comparison chart , and the overall comparison between semaglutide and tirzepatide provides much more actionable information than visual inspection
GLP-1 (glucagon-like peptide-1) receptor agonists are medications originally developed to treat type 2 diabetes and later approved for chronic weight management
AHK-Cu + BPC-157: BPC-157 promotes angiogenesis through VEGF/VEGFR2 pathways distinct from AHK-Cus copper-mediated VEGF upregulation
